In the following years, it was reported that CD4+ CD25+ T cells are increased in blood and tumors of patients with a variety of cancers, including breast, pancreatic, ovarian, and non-small-cell lung cancer (NSCLC) (Mougiakakos et al. 2010). This evidence concerns the gene CD4 and non-small cell lung carcinoma.